Core Viewpoint - The company, Hangzhou New Coordinate Technology Co., Ltd., announced a share reduction plan involving several directors and senior management due to personal financial needs [1] Group 1: Share Reduction Details - Four individuals, including Vice General Manager Yang Zhijun, Director Ren Haiyun, Secretary of the Board Zheng Xiaoling, and Financial Director Qu Wei, plan to reduce their holdings [1] - The total shares to be reduced amount to no more than 108,500 shares, representing up to 0.0795% of the company's total share capital [1] - Specific reduction plans include Yang Zhijun reducing up to 15,000 shares, Ren Haiyun up to 13,700 shares, Zheng Xiaoling up to 69,800 shares, and Qu Wei up to 10,000 shares [1] Group 2: Timing and Compliance - The reduction window is set from March 16, 2026, to June 16, 2026, with prices determined by market conditions at the time of implementation [1] - The company emphasizes that no reductions will occur during periods when legally prohibited [1] - The reduction plan will adhere to relevant regulations and timely information disclosure obligations [1]

Core Viewpoint - On February 13, there were no announcements of share buybacks, but several companies announced share reductions, indicating a trend of selling among major stakeholders [1][3]. Group 1: Companies Announcing Share Reductions - Zhaolong Interconnect: Directors Song Hongxia and Deputy General Manager Shen Fuliang plan to reduce their holdings by 0.0110% [2][4]. - Gaoc测股份: The controlling shareholder and three directors plan to collectively reduce their holdings by up to 3.19% [2][4]. - ST Yigou: Shareholder Hangzhou Haoyue intends to reduce holdings by no more than 2.5% [2][4]. - Xiandao Jidian: Shareholder Sanlin Wanye plans to reduce holdings by up to 2.05% [2][4]. - Guanghuan Xinwang: The controlling shareholder Baihuida intends to reduce holdings by up to 3% [2][4]. - Chunqiu Electronics: The controlling shareholder Xue Gewen plans to reduce holdings by up to 2% [2][4]. - New Coordinates: Shareholders plan to collectively reduce holdings by up to 0.0795% [2][4]. - Zejing Pharmaceutical: Shareholders plan to collectively reduce holdings by up to 1.0385% [2][4].

Group 1 - The humanoid robot industry is expected to enter a phase of large-scale production in 2026, with Tesla's Optimus moving from the lab to mass production, creating supply chain opportunities [1] - New Coordinates (603040) is highlighted as a key focus in the screw rod segment, emphasizing its potential for cost reduction and technological iteration in robotics [1] - This industry trend may positively impact the long-term business outlook for New Coordinates [1] Group 2 - On February 9, 2026, New Coordinates held its sixth second board meeting to review the election of independent directors, which is considered a routine operational matter with limited short-term impact on stock prices [2] Group 3 - Over the past week (February 7 to 13, 2026), New Coordinates' stock price has shown volatility, with a latest price of 104.20 yuan on February 13, down 3.13% from the closing price of 106.49 yuan on February 9, with a price fluctuation range of 7.00% [3] - During the same period, the automotive parts sector declined by 0.59%, and the overall market index (Shanghai Composite Index) showed weakness with a drop of 1.19%, indicating that the company's stock performance was slightly weaker than the industry but stronger than the overall market [3] - On February 13, there was a net inflow of 7.21 million yuan in main funds, indicating a high level of short-term investor interest [3]

Group 1 - RuiLian New Materials reported a total operating revenue of 1.677 billion yuan for 2025, an increase of 14.95% year-on-year, with a net profit of 311 million yuan, up 23.48% year-on-year [1] - China Shenhua's subsidiary, Guoneng Qingyuan Power, successfully put its fourth generator unit into commercial operation, expected to provide approximately 20 billion kWh of clean energy annually [2] - Qijiang Airlines announced a 6.04% year-on-year decline in passenger turnover for January 2026, with a passenger load factor of 84.03%, up 1.61% year-on-year [3] Group 2 - QiZheng Tibetan Medicine reported a total operating revenue of 2.416 billion yuan for 2025, a year-on-year increase of 3.34%, with a net profit of 646 million yuan, up 10.98% year-on-year [5] - QiaoYin Co. announced the termination of its artificial intelligence industry headquarters project due to changes in investment cooperation conditions [6] - New Point Software plans to use 90.81 million yuan of surplus raised funds for new projects, including AI-driven software development [7] Group 3 - High Measurement Co. announced plans for major shareholders and executives to reduce their holdings by up to 3.19% of the company's shares [8] - SAIC Group's subsidiary plans to establish a private equity fund with an initial scale of 2.5 billion yuan, focusing on solid-state batteries and chip localization [9] - Tianqi Lithium announced the resignation of its deputy general manager due to personal career planning [10] Group 4 - ZhongKong Technology reported a total operating revenue of 8.051 billion yuan for 2025, a decrease of 11.90%, with a net profit of 450 million yuan, down 59.70% year-on-year [11] - Spring Airlines reported a 6.28% year-on-year increase in total passenger volume for January 2026, with a total available ton-kilometers of 57,008.37 [12] - Qifan Cable's controlling shareholder reduced its stake by 3% through various trading methods [13] Group 5 - China Chemical signed contracts worth a total of 36.925 billion yuan in January 2026, with significant contracts exceeding 5 billion yuan totaling 11.371 billion yuan [19] - SaiTuo Bio received a CEP certificate for its raw material drug Betamethasone, which is used to treat allergies and autoimmune inflammation [20] - Giant Star Agriculture reported a sales revenue of 649 million yuan from commodity fat pigs in January 2026, with a sales volume of 404,400 pigs [23] Group 6 - Qinglong Pipe Industry's subsidiary won a 146 million yuan pipeline project [24] - Changshan Pharmaceutical announced that some of its products are expected to be selected for national centralized procurement [26] - Yangdian Technology completed the transfer of 12.96% of its shares through an agreement [27] Group 7 - Deepin Technology's investment fund introduced new limited partners and adjusted the capital contributions of some partners [28] - Qingyun Technology plans to pledge 25% of its shares for a loan application of up to 30 million yuan [29] - LaiMei Pharmaceutical reported a 57.20% year-on-year decline in net profit for 2025 [30] Group 8 - YouLiDe reported a 16.88% year-on-year decline in net profit for 2025, with total operating revenue of 1.221 billion yuan, up 7.99% [31] - Warner Pharmaceutical reported a net profit of 241 million yuan for 2025, an increase of 46.95% year-on-year [32] - LianRui New Materials reported a net profit of 293 million yuan for 2025, an increase of 16.42% year-on-year [33] Group 9 - HuaQin Technology expects a 24.28% year-on-year decrease in net profit for 2025, with projected revenue of 1.251 billion yuan, up 9.83% [34] - QiPai Technology's shareholder subscribed for 6.3 million shares, accounting for 5.49% of the total share capital [35] - Qilin Security's shareholders completed their planned share reductions without exceeding the original plan [36] Group 10 - Dameng Data announced the lifting of the detention of its senior vice president, allowing him to resume his duties [37] - Haiyou Engineering won a contract for the "NFPS COMP5" project worth approximately 4 billion USD, with the company's share exceeding 800 million USD [38] - Yatai Group plans to sell 20.81% of its shares in Northeast Securities, pending confirmation of financial statements [39]

Core Viewpoint - The company has established a global manufacturing and sales service system, with significant improvements in revenue and profitability from its wholly-owned subsidiaries in Europe and Mexico, indicating strong international customer recognition of its products and laying a solid foundation for future performance growth [1] Group 1 - The company set up wholly-owned subsidiaries, New Coordinates Europe and New Coordinates Mexico, in 2017 and 2018 [1] - The overseas revenue of the company has been continuously increasing, reflecting the positive performance in both commercial and passenger vehicle markets [1] - The ongoing growth in international markets demonstrates the high recognition of the company's products by global customers [1]

重要内容提示： 董事、高级管理人员持股的基本情况 本次减持计划实施前，杭州新坐标科技股份有限公司（以下简称"新坐标" 或"公司"）董事兼副总经理杨志军先生持有公司股份 60,000 股，占公司总股本 0.0440%；董事任海军先生持有公司股份 54,955 股，占公司总股本的 0.0403%； 副总经理兼董事会秘书郑晓玲女士持有公司股份 279,240 股，占公司总股本的 0.2046%；财务总监瞿薇女士持有公司股份 40,000 股，占公司总股本的 0.0293%。 减持计划的主要内容 证券代码：603040 证券简称：新坐标 公告编号：2026-008 杭州新坐标科技股份有限公司 董事、高级管理人员减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责 任。 2 上述减持主体无一致行动人。 二、减持计划的主要内容 | 股东名称 | 杨志军 | | | --- | --- | --- | | 计划减持数量 | 股 不超过：15,000 | | | 计划减持比例 | 不超过：0.0110% | | | 减持方式 ...

杭州新坐标科技股份有限公司 2026 年第一次临时股东会 会议资料 二〇二六年二月 | 2026 | 年第一次临时股东会须知 3 | | --- | --- | | 2026 | 年第一次临时股东会议案 5 | | 议案一 | 关于补选公司第六届董事会独立董事的议案 5 | 2026 年第一次临时股东会会议资料 杭州新坐标科技股份有限公司 2026 年第一次临时股东会议程 现场会议地点：杭州市余杭区仓前街道龙潭路 18 号公司一楼多功能室。 现场会议时间：2026 年 2 月 27 日 14:50。 网络投票时间：采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间 为股东会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过互联网 投票平台的投票时间为股东会召开当日的 9:15-15:00。 会议主持人：董事长徐纳先生。 会议议程： 2 一、与会人员签到（14:00—14:50）； 二、大会开始，主持人介绍本次股东会现场会议的出席情况； 三、宣读新坐标 2026 年第一次临时股东会会议须知； 四、推选计票人和监票人，宣读议案审议及表决办法； 五、宣读议案 ...

Core Viewpoint - The company announced that several executives plan to reduce their holdings in the company through centralized bidding transactions, totaling up to 108,500 shares, which represents a maximum of 0.0795% of the total share capital [1] Summary by Relevant Categories Executive Share Reduction - Executive Yang Zhijun intends to reduce his holdings by up to 15,000 shares, accounting for no more than 0.0110% of the total shares [1] - Executive Ren Haijun plans to reduce his holdings by up to 13,700 shares, representing no more than 0.0100% of the total shares [1] - Executive Zheng Xiaoling aims to reduce her holdings by up to 69,800 shares, which is no more than 0.0512% of the total shares [1] - Executive Qu Wei intends to reduce her holdings by up to 10,000 shares, accounting for no more than 0.0073% of the total shares [1] Reduction Period and Pricing - The reduction period is set from March 16, 2026, to June 16, 2026 [1] - The reduction price will be determined based on market prices [1]

Core Viewpoint - The humanoid robot sector is expected to gradually converge by 2026, with Tesla's Optimus moving from the laboratory phase to mass production, highlighting the need to focus on mass production certainty and new technological directions for efficiency improvement or significant cost reduction [1][2]. Industry Core Changes - The humanoid robot industry in 2025 saw significant order placements, primarily from government, data collection, and life service scenarios, with companies like Yuzhu, Zhiyuan, and UBTECH leading in shipment volumes [2]. - The prices of core robot components have significantly decreased due to industrial capital support, although there is still room for improvement in precision and lifespan [2]. - The model end has confirmed the correct path for VLA, with some models beginning to show intelligence, but the lack of sufficient data has prevented the formation of a scaling law cycle in the short term [2]. 2026 Strategy Outlook - The successful iteration of Tesla's Optimus is expected to lead to a large-scale production year in 2026, with key focus areas including Tier 1 suppliers, lead screws, and harmonic reducers, as the supply chain enters a contraction phase [3]. - For flexible robot targets, attention should be paid to technological iterations and cost reduction, with key drivers including improvements in dexterous hands, motors, and lightweight materials [3]. Investment Recommendations - For certainty in direction, focus on Tier 1 suppliers such as Sanhua Intelligent Control and Top Group, lead screws from Hengli Hydraulic and Zhejiang Rongtai, and harmonic reducers from Lide Harmonic and Siling Intelligent Drive [4]. - For technological transformation and cost reduction, key companies to watch include Zhaowei Electromechanical and Hanwei Technology for dexterous hands and electronic skin, Hengshuai Co. and Buke Co. for motors, and Hengbo Co. and Xingyuan Zhuomei for lightweight materials [4].

Core Insights - The Science and Technology Innovation Board (STAR Market) has welcomed a new company, Electric Science and Technology Blue Sky, bringing the total number of listed companies to 603, highlighting its role as a hub for "hard technology" enterprises in China [2] - The STAR Market Composite Index has gained significant attention, with a sample size of 580 stocks and a market capitalization coverage exceeding 90%, indicating a notable growth effect [2][3] - Nearly 60% of STAR Market companies have reported a year-on-year increase in net profit, with 39 companies experiencing a substantial growth of over 100% [3] STAR Market Overview - The STAR Market is characterized by a development pattern of "chain leader guidance and upstream-downstream collaboration," particularly in strategic emerging industries such as new-generation information technology, biomedicine, and high-end equipment manufacturing [2] - The STAR Market Composite Index has become one of the four core broad-based indices in A-shares, providing a vital tool for domestic and international investors to observe and share in the dividends of China's new productive forces [2] Performance and Growth - As of February 9, 2026, 391 companies on the STAR Market have disclosed their expected performance for 2025, with over 60% of them showing a year-on-year increase in net profit [3] - The total R&D investment of STAR Market companies reached 132.864 billion yuan in the first three quarters of 2025, which is 2.7 times the net profit of the sector, with a median R&D investment ratio of 12.5% of operating income, significantly higher than other A-share sectors [3] Reform and Development - The STAR Market has undergone three rounds of systematic reforms aimed at enhancing the inclusiveness and adaptability of the capital market, supporting various types of companies, including unprofitable and special equity structure enterprises [4] - Since the introduction of the "STAR Market Eight Articles," over 170 new merger and acquisition transactions have been recorded, totaling more than 90 billion yuan, with a transaction completion rate of nearly 70% [5] Index and Product Ecosystem - The STAR Market Composite Index has shown a steady upward trend since its launch, with an increase of approximately 63% as of February 10, 2026 [6] - A complete product chain has been established, including ETFs, linked funds, and enhanced products, with 49 fund managers launching a total of 81 STAR Market Composite Index funds, achieving a combined scale of 25.8 billion yuan [6]